Albany, NY -- (SBWIRE) -- 12/09/2013 -- Cancer biomarkers serve as an indicator of normal biological processes, pharmacologic response or pathogenic processes, to a therapeutic intervention. These biomarkers are used for prognosis, in order to predict the causes of a tumor. A doctor can also decide with the help of the biomarkers what dose might be most effective for the patients and which patient will respond positively to a given drug.

Browse Full Report: - http://www.transparencymarketresearch.com/cancer-biomarkers-market.html

As the area of drug development is facing new challenges and the cost of drug development is increasing, biomarkers are widely used by the pharmaceutical companies to overcome these challenges. Several new companies are emerging, in order to provide advanced technology platforms in different areas such as transcriptomics, genomics, metabolomics, bioinformatics and pharmacogenomics and this is serving as an important driver for the biomarkers market.

Scientific advancement in these areas by different companies is likely to drive the biomarkers market further in the future. It will also enhance detection levels and improve sample throughputs in preclinical research, increase utility in diagnostics and product commercialization.

The global biomarkers market was worth USD $13.16 billion in 2011. It is expected to reach USD 29.78 billon by 2018, growing at a CAGR of 14.60% from 2011 to 2018. Oncology has the largest market share at present, but cardiology is expected to grow at the fastest rate with a CAGR of 16.40% from 2011 to 2018. Among the different regions of the world North America is recorded as the leading biomarker market, due to rapid growth of IT industry in these regions and high adoption rate of throughput technologies, for the discovery of biomarkers.

Some of the major players in this market are Abbott Laboratories,Correlogic Systems, Inc, Agendia Bv,Biocurex Inc,Astellas Pharma Us Inc, Beckman Coulter, Inc, Becton, Dickinson And Company, Biomerieux S.A., Biomoda, Inc, Clarient, Inc, Ambrilia Biopharma,Diadexus, Inc, Affymetrix, Inc and Aureon Laboratories, Inc. The companies are implementing several business strategies such as new product launches, mergers, acquisitions, partnerships, joint ventures and so on. These business strategies are further expected to drive the global biomarker market in the coming future.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World

This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

More Reports on Pharmaceutical Market: - http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:- http://www.tmrblog.com/
http://www.sandyresearcher.com/
http://sandyresearcher.wordpress.com/